Related Experiment Video
Updated: Apr 19, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.4K
Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention
Summary
Achieving tuberculosis (TB) targets requires a shift in strategy for high HIV prevalence areas. A comprehensive, funded approach to TB treatment and prevention is essential until new interventions are developed.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Global Health Policy
Background:
- Global tuberculosis (TB) incidence is declining, but progress towards Millennium Development Goal (MDG) targets remains insufficient.
- High human immunodeficiency virus (HIV) prevalence settings present unique challenges to TB control efforts.
- Current strategies may not be adequate to meet ambitious TB reduction goals without adaptation.
Purpose of the Study:
- To evaluate the impact of current TB control strategies in high HIV prevalence settings.
- To identify essential components for accelerating progress towards eliminating new TB infections, deaths, and suffering.
- To inform policy and resource allocation for effective TB response.
Main Methods:
- Two independent mathematical modeling exercises were conducted using South African data.
- Models incorporated different structures and assumptions to assess TB control scenarios.
- Analysis focused on the period until new TB drugs, diagnostics, and vaccines become available.
Main Results:
- Current TB control approaches are unlikely to achieve MDG targets without strategic adjustments.
- A fully funded and accessible combination strategy for TB treatment and prevention is crucial.
- Local TB epidemiology and evidence-informed policy are key determinants of success.
Conclusions:
- A paradigm shift in the global TB response is necessary, particularly in high HIV settings.
- Integrated TB treatment and prevention strategies, informed by local data, are vital.
- Sustained progress towards zero TB requires immediate and comprehensive action, even in the absence of novel interventions.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
943
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
943
Pulmonary Tuberculosis IV
762
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
762
Pulmonary Tuberculosis I
1.6K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
Pulmonary Tuberculosis II
2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pulmonary Tuberculosis III
1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K

